Interpersonal Psychotherapy for Youth With Severe Mood Dysregulation
2 other identifiers
interventional
31
1 country
1
Brief Summary
The purpose of this study is to determine the feasibility and acceptability of utilizing an adapted form (i.e. IPT-MBD) of a psychosocial intervention, Interpersonal Psychotherapy for Depressed Adolescents, for youth with severe mood dysregulation (SMD) or disruptive mood dysregulation disorder (DMDD). The investigators hypothesize that retention rates will be \>80%, satisfaction scores will average 6 (high) on a 7 point satisfaction scale, and that youth who receive the IPT intervention will have overall improvement in SMD/DMDD symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2013
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 10, 2013
CompletedFirst Posted
Study publicly available on registry
October 14, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2015
CompletedMay 24, 2017
May 1, 2017
2.2 years
October 10, 2013
May 22, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Retention rate
To describe/assess feasibility of IPT-MBD, investigators will look at ease of recruitment and retention rate goal of at least 80%. Investigators will collect data on the number of subjects recruited, enrolled, and who followed the protocol for 24 weeks. Investigators will comment on adherence to the overall study, as well as to specific treatment visits.
24 weeks
Secondary Outcomes (2)
Clinical Global Impressions Scale for SMD/DMDD (CGI-SMD/DMDD)
24 weeks
Satisfaction
24 weeks
Study Arms (2)
Treatment as Usual (TAU)
ACTIVE COMPARATORParticipants who are not randomly assigned to the IPT-MBD group will continue with treatment at usual, which is considered routine care.
IPT-MBD
OTHERWeekly Interpersonal Therapy for SMD/DMDD (IPT-MBD) sessions, which emphasizes building skills in managing relationships, helping with problem solving, strengthening communication skills and other skills.
Interventions
IPT-MBD is a modified form of Interpersonal Psychotherapy for Depressed Adolescents (IPT-A), which emphasizes building skills in managing relationships, helping with problem solving, and strengthening communication skills.
Eligibility Criteria
You may qualify if:
- Male and female subjects, ages 12 to 17 years, who meet criteria for severe mood dysregulation (SMD) as defined by NIMH criteria or for disruptive mood dysregulation disorder (DMDD).
- Subject has an estimated IQ \>70 on the Kaufman Brief Intelligence Test (KBIT-
- Subjects will have continuously resided with a legal guardian who has known the adolescent well for at least one year before study entry and is legally able to sign the consent form.
- Children's Global Assessment Scale (CGAS) ≤ 60
- CGI-S (SMD) ≥ 4
- Participant and guardian must agree to have therapy sessions audiotaped for training purposes.
You may not qualify if:
- Subject poses a significant risk for dangerousness to self or others. Risk will be determined by clinical history, clinical diagnostic interview and KSADS-PL interview of parent and patient by clinician.
- Subject suffers from a concomitant medical or psychiatric comorbidity that makes this study protocol inadvisable (either the treatment is contraindicated or the disorder is not the primary focus of treatment).
- Subject meets DSM-IV criteria for current alcohol or substance dependence or current use (defined as the past 4 weeks).
- Primary caretaker does not speak English or is not capable of completing study measures.
- Pregnant females.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Johns Hopkins University Bayview Medical Center
Baltimore, Maryland, 21224, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Leslie Miller, MD
Johns Hopkins University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
October 10, 2013
First Posted
October 14, 2013
Study Start
August 1, 2013
Primary Completion
October 1, 2015
Study Completion
October 1, 2015
Last Updated
May 24, 2017
Record last verified: 2017-05